Addressing the Declining Rates of Completion and Gender Coverage Inequity in Human Papillomavirus Vaccination in the United States

Affiliations

Editorial

Franklin D Pratt. Am J Public Health. 2018 Jul.

. 2018 Jul;108(7):853-854.

doi: 10.2105/AJPH.2018.304479.

¹ Franklin D. Pratt is with the Vaccine Preventable Disease Control Program, Department of Public Health, County of Los Angeles, Los Angeles, CA.

No abstract available

Comment on

Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients.
Spencer JC, Brewer NT, Trogdon JG, Wheeler SB, Dusetzina SB. Spencer JC, et al. Am J Public Health. 2018 Jul;108(7):946-950. doi: 10.2105/AJPH.2018.304408. Epub 2018 May 17. Am J Public Health. 2018. PMID: 29771616 Free PMC article.

1. Ackerson B, Hechter R, Sidell M et al. Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization. Vaccine. 2017;35(6):897–902. - PubMed
1. Daley EM, Vamos CA, Thompson EL et al. The feminization of HPV: how science, politics, economics and gender norms shaped U.S. HPV vaccine implementation. Papillomavirus Res. 2017;3:142–148. - PMC - PubMed
1. Centers for Disease Control and Prevention. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(33):874–882. - PMC - PubMed
1. Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781–789. - PMC - PubMed
1. Han JJ, Beltran TH, Song JW, Klaric J, Choi YS. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health and Nutrition Examination Survey (NHANES) 2013–2014. JAMA Oncol. 2017;3(6):810–816. - PMC - PubMed